Clinical Trial Update: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over) [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase III crossover study evaluating allogeneic ABCB5-positive dermal mesenchymal stromal cells for Epidermolysis bullosa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa

Drugs mentioned

• Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells (ABCB5-positive dermal mesenchymal stromal cells)

Snippet

Sponsor: RHEACELL GmbH & Co. KG | Conditions: Epidermolysis Bullosa | Phase 3 | Status: ACTIVE_NOT_RECRUITING